MicroRNAs and diabetic complications.

Journal of Cardiovascular Translational Research
Rama NatarajanMitsuo Kato

Abstract

Both Type 1 and Type 2 diabetes can lead to debilitating microvascular complications such as retinopathy, nephropathy and neuropathy, as well as macrovascular complications such as cardiovascular diseases including atherosclerosis and hypertension. Diabetic complications have been attributed to several contributing factors such as hyperglycemia, hyperlipidemia, advanced glycation end products, growth factors, and inflammatory cytokines/chemokines. However, current therapies are not fully efficacious and hence there is an imperative need for a better understanding of the molecular mechanisms underlying diabetic complications in order to identify newer therapeutic targets. microRNAs (miRNAs) are short non-coding RNAs that repress target gene expression via post-transcriptional mechanisms. Emerging evidence shows that they have diverse cellular and biological functions and play key roles in several diseases. In this review, we explore the role of miRNAs in the pathology of diabetic complications and also discuss the potential use of miRNAs as novel diagnostic and therapeutic targets for diabetic complications.

References

Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T YamamotoW A Border
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
May 22, 2002·JAMA : the Journal of the American Medical Association·Joshua A BeckmanPeter Libby
Apr 23, 2003·Journal of the American Society of Nephrology : JASN·Fuad N Ziyadeh, Kumar Sharma
Apr 1, 2004·Endocrinology and Metabolism Clinics of North America·Zhiheng He, George L King
Apr 14, 2004·Archives of Ophthalmology·John H KempenUNKNOWN Eye Diseases Prevalence Research Group
May 29, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Rama Natarajan, Jerry L Nadler
Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Sep 17, 2004·Nature·Victor Ambros
Apr 27, 2005·Nature Reviews. Molecular Cell Biology·V Narry Kim
Sep 6, 2005·Science·Phillip D Zamore, Benjamin Haley
Nov 1, 2005·Nature·Jan KrützfeldtMarkus Stoffel
Aug 25, 2006·Nature Methods·Ola Snøve, John J Rossi
Nov 17, 2006·Proceedings of the National Academy of Sciences of the United States of America·Eva van RooijEric N Olson
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mitsuo KatoRama Natarajan
May 1, 2007·Nature Medicine·Alessandra CarèGianluigi Condorelli
Aug 19, 2007·Nature Methods·Margaret S EbertPhillip A Sharp
Jan 17, 2008·Nature Reviews. Genetics·Witold FilipowiczNahum Sonenberg
Feb 14, 2008·Nature Reviews. Molecular Cell Biology·Giovanni Stefani, Frank J Slack
Mar 28, 2008·Nature·Joacim ElménSakari Kauppinen
Jun 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Louisa M VilleneuveRama Natarajan
Jul 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Patrick S MitchellMuneesh Tewari
Aug 22, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Qiang WangRichard J Quigg
Feb 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kai WangDavid J Galas
Jul 8, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Mitsuo KatoRama Natarajan
Jul 21, 2009·RNA·Guihua SunJohn J Rossi
Sep 19, 2009·Nature Reviews. Genetics·Carlo M Croce
Dec 17, 2009·Diabetes/metabolism Research and Reviews·Biao FengSubrata Chakrabarti
Jan 9, 2010·Journal of the American Society of Nephrology : JASN·Aleksandra KrupaDonald Fraser
Feb 27, 2010·Circulation Research·Anke J TijsenYigal M Pinto
Mar 6, 2010·Expert Review of Endocrinology & Metabolism·Sridevi DevarajIshwarlal Jialal
Apr 7, 2010·Disease Markers·Gang WangCheuk-Chun Szeto
May 15, 2010·Expert Review of Molecular Diagnostics·Muller Fabbri

❮ Previous
Next ❯

Citations

May 15, 2013·Current Diabetes Reports·Johanna K DiStefanoM Lucrecia Alvarez
Jul 4, 2012·Journal of Cardiovascular Translational Research·Helen D Nickerson, Sanjoy Dutta
Feb 28, 2013·Cardiology in the Young·Ahmed OmranFei Yin
Nov 14, 2013·PloS One·Federica BaruttaGabriella Gruden
Feb 27, 2014·Diabetologia·Rokhsana MortuzaSubrata Chakrabarti
Jul 15, 2015·Experimental and Therapeutic Medicine·X I JiangZhigang Cao
Jan 8, 2014·Life Sciences·Biao FengSubrata Chakrabarti
Sep 10, 2013·Seminars in Nephrology·Maria R WingDominic S Raj
Oct 15, 2013·International Journal of Cancer. Journal International Du Cancer·Vanessa Lopes-RodriguesM Helena Vasconcelos
Oct 14, 2014·Life Sciences·Biao FengSubrata Chakrabarti
Sep 26, 2013·Clinical Science·Aaron D McClelland, Phillip Kantharidis
Jun 19, 2013·Free Radical Biology & Medicine·Mitsuo KatoRama Natarajan
Jan 13, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yu ZhouWen-Zhe Ho
Jan 26, 2016·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Carlos ZgheibJunwang Xu
Apr 29, 2016·International Journal of Obesity : Journal of the International Association for the Study of Obesity·W GuoS Hu
Jul 5, 2016·Journal of Diabetes Research·Olga Simó-ServatCristina Hernández
Jan 11, 2017·Clinical and Experimental Hypertension : CHE·Jessica Edith RodríguezSantiago Villafaña
Nov 11, 2014·Journal of Cardiovascular Pharmacology·Gnanapragasam ArunachalamChris R Triggle
Jan 27, 2017·Journal of Movement Disorders·Pratik ShahSeong Wook Yang
Nov 28, 2017·European Journal of Clinical Investigation·Bao-Wei WangKou-Gi Shyu
May 1, 2013·Nature Reviews. Endocrinology·Claudiane Guay, Romano Regazzi
Aug 6, 2018·Journal of Cellular Physiology·Alireza MafiZatollah Asemi
Feb 6, 2015·Journal of Hematology & Oncology·Maria Braoudaki, George I Lambrou
Mar 8, 2019·Biological & Pharmaceutical Bulletin·Hua ShenGuojun Wang
Jan 27, 2019·Diabetes/metabolism Research and Reviews·Mae SeleemHeba A Ewida
Jun 4, 2019·Expert Opinion on Therapeutic Targets·Annabelle M WarrenMark E Cooper
Nov 20, 2013·Current Opinion in Nephrology and Hypertension·Aaron McClellandPhillip Kantharidis
Jun 19, 2015·World Journal of Hepatology·Iván Lyra-GonzálezJuan Armendáriz-Borunda

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.